PLEASANTON, Calif., Aug. 3, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2023. Recent Highlights Revenue was $146.8 million for the second quarter, representing a…
